Avalon GloboCare Announces Commercial Launch of KetoAir Breathalyzer at the KetoCon…
<!-- Name:DistributionId Value:8808777 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Avalon GloboCare Corp.
Avalon GloboCare Announces the Deployment of Breakthrough Fusion Gene Map Technology
FREEHOLD, N.J., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a leading global developer of innovative cell-based technologies and…
Avalon GloboCare Receives Allowance for Joint U.S. Patent
FREEHOLD, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies and therapeutics, today provided…
Avalon GloboCare Announces New Study Featuring AI-Enhanced Protein Design Technology…
FREEHOLD, N.J., June 30, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies and therapeutics, today announced…
Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference
FREEHOLD, N.J., May 25, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies and therapeutics, announced today…
Avalon GloboCare Provides Year-End Business Update of Selective Scientific and…
Company continues to expand and accelerate its R&D strategies for high-impact translational and clinical programs in the US and Europe Intended SenlangBio acquisition terminated,…
Avalon GloboCare Jointly Files US and International Patent Application for…
Co-developed novel technology platform combining S-layer proteins and emulsomes for diverse applications in bio-delivery of drugs and genes with the University of Natural Resources and Life…